Thabaut A, Meyran M
Laboratoire de Microbiologie, Hôpital Militaire Bégin, Saint-Mande.
Pathol Biol (Paris). 1989 Jun;37(5 Pt 2):595-9.
The in vitro activity of antibiotic combinations of teicoplanin (T) and ceftriaxone (C) was evaluated on 10 methicillin sensitive S. aureus (MSSA), 10 methicillin resistant S. aureus (MRSA), 4 Enterococcus and 2 E. coli. By the checkerboard method the combination T + C showed synergism against 9 MRSA, 2 MSSA, 4 Enterococcus, indifferent effect against the other strains. By the time-kill-curves method synergism was found for the combinations T + C at 1/2 CMI against MRSA, MSSA and Enterococcus, and indifference with the combinations at 1 X CMI, 2 X CMI, 4 X CMI against all the strains. Antagonistic effect was never found. These results suggest that teicoplanin in combination with ceftriaxone can be tested in in vivo study to demonstrate the possible benefits of the synergism particularly in the therapy of the nosocomial infections.
对10株甲氧西林敏感金黄色葡萄球菌(MSSA)、10株甲氧西林耐药金黄色葡萄球菌(MRSA)、4株肠球菌和2株大肠杆菌评估了替考拉宁(T)和头孢曲松(C)抗生素组合的体外活性。通过棋盘法,T+C组合对9株MRSA、2株MSSA、4株肠球菌显示出协同作用,对其他菌株无作用。通过时间杀菌曲线法,发现T+C组合在1/2 CMI时对MRSA、MSSA和肠球菌有协同作用,在1×CMI、2×CMI、4×CMI时对所有菌株无作用。从未发现拮抗作用。这些结果表明,替考拉宁与头孢曲松联合应用可进行体内研究,以证明协同作用可能带来的益处,特别是在医院感染的治疗中。